Cochlear Implants Versus Hearing Aids in Children With Auditory Neuropathy Spectrum Disorder: A Systematic Review
8 affiliations
- 1Faculty of Medicine, Jazan University, Jazan, SAU
- 2General Practice, Jouf University, Aljouf, SAU
- 3College of Medicine, King Khalid University, Abha, SAU
- 4College of Medicine, Umm AlQura University, Makkah, SAU
- 5Faculty of Medicine, Dar Al Uloom University, Riyadh, SAU
- 6Faculty of Medicine, Tanta University, Tanta, EGY
- 7Faculty of Medicine, Tabuk University, Tabuk, SAU
- 8Faculty of Medicine, Batterjee Medical Collage, Jeddah, SAU
Abstract
Auditory neuropathy spectrum disorder (ANSD) is a heterogeneous hearing disorder characterized by impaired auditory neural synchrony and variable auditory and communication outcomes. Hearing aids (HAs) are commonly used as initial treatment, whereas cochlear implantation (CI) may be considered for children who show inadequate progress with amplification. This systematic review compared auditory and communication outcomes of CI and HAs in children with ANSD. PubMed/MEDLINE, Web of Science, Scopus, and the Cochrane Central Register of Controlled Trials were searched through 6 August 2026 for comparative studies reporting quantitative auditory or communication outcomes for both CI and HA groups. Because outcomes were reported using heterogeneous measures and formats, findings were synthesized narratively, with one dichotomous outcome analyzed quantitatively. Open-set speech perception outcomes showed substantial overlap between children using CI and HAs, and no study demonstrated a statistically significant difference between devices. In one study, at least 60% open-set speech perception was achieved by 6/16 (37.5%) children with CI and 4/8 (50.0%) children with HAs, with no statistically significant difference. Closed-set speech perception was achieved by 14/16 (87.5%) children with CI and 6/8 (75.0%) children with HAs. Language outcomes were also broadly similar between treatment groups. Some children who showed inadequate progress with HAs subsequently achieved useful open-set speech perception after CI. Current evidence does not establish a clear difference in auditory or communication outcomes between CI and HAs in children with ANSD. Treatment decisions should be individualized according to auditory development, response to amplification, speech perception, language development, and other relevant clinical factors. Further prospective comparative studies using standardized outcome measures are needed.
Related
- Temporal Auditory Resolution, Timed Motor Responses to Auditory Cues, and Phonological Processing in Swedish Children with Cochlear Implants and Normal Hearing Peers.
- Multichannel optical cochlear implants enable spectrally distinct auditory activity
- Cortical P1 Latency, Sound Field Audiometry, and Speech Audiometry in Children with Sequential Bilateral Cochlear Implants: A Comparative Pilot Study
- Multicentre phase III randomised controlled trial to evaluate effectiveness of the Both EARS (BEARS) virtual reality training package to maximise hearing abilities in children and young people with bilateral cochlear implants: the BEARS protocol
- KDM6A Haploinsufficiency Is Insufficient to Disrupt Cochlear Structure and Auditory Function in Mouse Models of Kabuki Syndrome Type 2
BibTeX
@article{swaid2026cochlear,
title = {{Cochlear Implants Versus Hearing Aids in Children With Auditory Neuropathy Spectrum Disorder: A Systematic Review}},
author = {Ali I Swaid and Reham T Alruwaili and Mazen A Alayidh and Abdulmajeed M Alwzynani and Hussain M Reda and Hassan H AlAli and Atallah A Almadi and Ali A Alshehri and Yasser H Alatawi and Raed H Aljabri and Refal Morea},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.117160},
url = {https://europepmc.org/article/PMC/PMC13719000},
note = {CC BY},
}
RIS
TY - JOUR
TI - Cochlear Implants Versus Hearing Aids in Children With Auditory Neuropathy Spectrum Disorder: A Systematic Review
AU - Ali I Swaid
AU - Reham T Alruwaili
AU - Mazen A Alayidh
AU - Abdulmajeed M Alwzynani
AU - Hussain M Reda
AU - Hassan H AlAli
AU - Atallah A Almadi
AU - Ali A Alshehri
AU - Yasser H Alatawi
AU - Raed H Aljabri
AU - Refal Morea
PY - 2026
DA - 2026/09/29
JO - Cureus
DO - 10.7759/cureus.117160
UR - https://europepmc.org/article/PMC/PMC13719000
AB - Auditory neuropathy spectrum disorder (ANSD) is a heterogeneous hearing disorder characterized by impaired auditory neural synchrony and variable auditory and communication outcomes. Hearing aids (HAs) are commonly used as initial treatment, whereas cochlear implantation (CI) may be considered for children who show inadequate progress with amplification. This systematic review compared auditory and communication outcomes of CI and HAs in children with ANSD. PubMed/MEDLINE, Web of Science, Scopus, and the Cochrane Central Register of Controlled Trials were searched through 6 August 2026 for comparative studies reporting quantitative auditory or communication outcomes for both CI and HA groups. Because outcomes were reported using heterogeneous measures and formats, findings were synthesized narratively, with one dichotomous outcome analyzed quantitatively. Open-set speech perception outcomes showed substantial overlap between children using CI and HAs, and no study demonstrated a statistically significant difference between devices. In one study, at least 60% open-set speech perception was achieved by 6/16 (37.5%) children with CI and 4/8 (50.0%) children with HAs, with no statistically significant difference. Closed-set speech perception was achieved by 14/16 (87.5%) children with CI and 6/8 (75.0%) children with HAs. Language outcomes were also broadly similar between treatment groups. Some children who showed inadequate progress with HAs subsequently achieved useful open-set speech perception after CI. Current evidence does not establish a clear difference in auditory or communication outcomes between CI and HAs in children with ANSD. Treatment decisions should be individualized according to auditory development, response to amplification, speech perception, language development, and other relevant clinical factors. Further prospective comparative studies using standardized outcome measures are needed.
SN - 2168-8184
ER -